LIGAND PHARM Management Performance Evaluation

LGNZZ -- USA Stock  

USD 0.12  0.01  8.00%

Analysis of LIGAND PHARM manpower and management performance can provide insight into LIGAND PHARM stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with LIGAND PHARM INC future performance. Please see also Stocks Correlation.
Symbol  LGNZZ
Name  LIGAND PHARM INC
TypeStock
Country   United States
Exchange  OTC

Information on LIGAND PHARM INC Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out.

Currently Trending

GM   
Purchased over 70 shares of
a day ago
Traded for 35.02
CRM   
Purchased a lot of shares of
a day ago
Traded for 154.92
MSFT   
Purchased over 20 shares of
a day ago
Traded for 112.14
F   
Purchased over 300 shares of
a day ago
Traded for 9.55
S   
Purchased over 400 shares of
a day ago
Traded for 6.33

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

LIGAND PHARM INC Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of seventeen. LIGAND PHARM INC Price Series Summation is a cross summation of LIGAND PHARM price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add LIGAND PHARM INC to your portfolio
Please see also Stocks Correlation. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com